84 related articles for article (PubMed ID: 8974563)
1. [The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites].
Boĭko SS; Zherdev VP; Gudasheva TA; Vasilevich NI; Ostrovskaia RU; Voronina TA; Rozantsev GG
Eksp Klin Farmakol; 1996; 59(2):38-40. PubMed ID: 8974563
[TBL] [Abstract][Full Text] [Related]
2. [The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites].
Boĭko SS; Zherdev VP; Dvorianinov AA; Gudasheva TA; Ostrovskaia RU; Voronina TA; Rozantsev GG; Seredenin SB
Eksp Klin Farmakol; 1997; 60(2):53-5. PubMed ID: 9206571
[TBL] [Abstract][Full Text] [Related]
3. [Fast thin-layer densitometric determination of the nootropic piracetam in biological material].
Bockhard H; Oelschläger H; Pooth R
Pharmazie; 1997 May; 52(5):357-61. PubMed ID: 9229717
[TBL] [Abstract][Full Text] [Related]
4. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine.
Gudasheva TA; Boyko SS; Ostrovskaya RU; Voronina TA; Akparov VK; Trofimov SS; Rozantsev GG; Skoldinov AP; Zherdev VP; Seredenin SB
Eur J Drug Metab Pharmacokinet; 1997; 22(3):245-52. PubMed ID: 9358206
[TBL] [Abstract][Full Text] [Related]
5. Determination of piracetam and its impurities by TLC.
Ovalles JF; Tettey JN; Miller JH; Skellern GG
J Pharm Biomed Anal; 2000 Sep; 23(4):757-61. PubMed ID: 10975251
[No Abstract] [Full Text] [Related]
6. New validated method for piracetam HPLC determination in human plasma.
Curticapean A; Imre S
J Biochem Biophys Methods; 2007 Jan; 69(3):273-81. PubMed ID: 16842859
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of the nootropic drugs].
Boĭko SS; Vitskova GIu; Zherdev VP
Eksp Klin Farmakol; 1997; 60(6):62-70. PubMed ID: 9460604
[No Abstract] [Full Text] [Related]
8. High-performance liquid chromatographic and megabore gas-liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extraction.
Vermeij TA; Edelbroek PM
J Chromatogr B Biomed Appl; 1994 Dec; 662(1):134-9. PubMed ID: 7894687
[TBL] [Abstract][Full Text] [Related]
9. Development of a SPE/HPLC/DAD method for the determination of antileishmanial 2-substituted quinolines and metabolites in rat plasma.
Desrivot J; Moussa F; Champy P; Fournet A; Figadère B; Herrenknecht C
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):230-8. PubMed ID: 17499564
[TBL] [Abstract][Full Text] [Related]
10. HPLC determination of midazolam and its three hydroxy metabolites in perfusion medium and plasma from rats.
Jurica J; Dostálek M; Konecný J; Glatz Z; Hadasová E; Tomandl J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):571-7. PubMed ID: 17350905
[TBL] [Abstract][Full Text] [Related]
11. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
12. Sensitive chiral high-performance liquid chromatographic determination of anthelmintic flubendazole and its phase I metabolites in blood plasma using UV photodiode-array and fluorescence detection Application to pharmacokinetic studies in sheep.
Nobilis M; Vybíralová Z; Krízová V; Kubícek V; Soukupová M; Lamka J; Szotáková B; Skálová L
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):89-96. PubMed ID: 19004671
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress.
Andreeva NA; Stel'mashuk EV; Isaev NK; Ostrovskaya RU; Gudasheva TA; Viktorov IV
Bull Exp Biol Med; 2000 Oct; 130(10):969-72. PubMed ID: 11177296
[TBL] [Abstract][Full Text] [Related]
14. Determination of piracetam in human plasma and urine by liquid chromatography.
Louchahi K; Tod M; Bonnardel P; Petitjean O
J Chromatogr B Biomed Appl; 1995 Jan; 663(2):385-9. PubMed ID: 7735487
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic method with UV photodiode-array, fluorescence and mass spectrometric detection for simultaneous determination of galantamine and its phase I metabolites in biological samples.
Maláková J; Nobilis M; Svoboda Z; Lísa M; Holcapek M; Kvetina J; Klimes J; Palicka V
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):265-74. PubMed ID: 17416214
[TBL] [Abstract][Full Text] [Related]
16. Isolation of two Ochrobactrum sp. strains capable of degrading the nootropic drug-Piracetam.
Woźniak-Karczewska M; Čvančarová M; Chrzanowski Ł; Kolvenbach B; Corvini PF; Cichocka D
N Biotechnol; 2018 Jul; 43():37-43. PubMed ID: 28720419
[TBL] [Abstract][Full Text] [Related]
17. Quantitative determination of astilbin in rabbit plasma by liquid chromatography.
Guo J; Xu Q; Chen T
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):357-60. PubMed ID: 15135113
[TBL] [Abstract][Full Text] [Related]
18. Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.
Contin M; Martinelli P; Albani F; Scaglione C; Avoni P; Rizzo G; Baruzzi A
Clin Neuropharmacol; 2007; 30(2):122-4. PubMed ID: 17414945
[No Abstract] [Full Text] [Related]
19. [Design of the novel dipeptide neuropsychotropic drug preparations].
Gudasheva TA; Skoldinov AP
Eksp Klin Farmakol; 2003; 66(2):15-9. PubMed ID: 12962042
[TBL] [Abstract][Full Text] [Related]
20. Performance characteristics of a new levetiracetam immunoassay and method comparison with a high-performance liquid chromatography method.
Reineks EZ; Lawson SE; Lembright KE; Wang S
Ther Drug Monit; 2011 Feb; 33(1):124-7. PubMed ID: 21157399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
